Filed: 11/14/2025ACC: 0000921895-25-003089
📋 What this filing means
BVF INC/IL filed this quarterly 13F‑HR report disclosing 46 equity positions with a total reported market value of $2.47B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
46
Positions
$2.47B
Total AUM (reported)
191.20M
Total Shares
Allocation by class
COM$1.60B64.7%
COM NEW$340.68M13.8%
CLASS A ORD$141.62M5.7%
SPONSORED ADS$137.09M5.6%
ORDINARY SHARES$126.24M5.1%
ADS$66.19M2.7%
SHS$57.29M2.3%
Portfolio Concentration
Top 3$667.20M27.0%
4–10$778.69M31.6%
11–25$799.87M32.4%
Rest$221.15M9.0%
Top 3 weight
27.0%
Top 10 weight
58.6%
Voting Authority Distribution
Total shares with voting rights: 191.20M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
191.20M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other46
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings46
Rows:
KYMERA THERAPEUTICS INC
DFNDShares5.50M
TypeSH
Market value$311.45M
12.63%
Sole
0.00
Shared
5.50M
None
0.00
REVOLUTION MEDICINES INC
DFNDShares3.97M
TypeSH
Market value$185.63M
7.52%
Sole
0.00
Shared
3.97M
None
0.00
PROTAGONIST THERAPEUTICS INC
DFNDShares2.56M
TypeSH
Market value$170.12M
6.90%
Sole
0.00
Shared
2.56M
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares19.75M
TypeSH
Market value$141.62M
5.74%
Sole
0.00
Shared
19.75M
None
0.00
CIDARA THERAPEUTICS INC
DFNDShares1.41M
TypeSH
Market value$135.42M
5.49%
Sole
0.00
Shared
1.41M
None
0.00
GH RESEARCH PLC
DFNDShares8.83M
TypeSH
Market value$126.24M
5.12%
Sole
0.00
Shared
8.83M
None
0.00
MIRUM PHARMACEUTICALS INC
DFNDShares1.50M
TypeSH
Market value$109.62M
4.44%
Sole
0.00
Shared
1.50M
None
0.00
XOMA ROYALTY CORPORATION
DFNDShares2.59M
TypeSH
Market value$99.83M
4.05%
Sole
0.00
Shared
2.59M
None
0.00
STRUCTURE THERAPEUTICS INC
DFNDShares3.20M
TypeSH
Market value$89.71M
3.64%
Sole
0.00
Shared
3.20M
None
0.00
KURA ONCOLOGY INC
DFNDShares8.62M
TypeSH
Market value$76.26M
3.09%
Sole
0.00
Shared
8.62M
None
0.00
SEPTERNA INC
DFNDShares4.02M
TypeSH
Market value$75.54M
3.06%
Sole
0.00
Shared
4.02M
None
0.00
PALVELLA THERAPEUTICS INC NE
DFNDShares1.16M
TypeSH
Market value$72.80M
2.95%
Sole
0.00
Shared
1.16M
None
0.00
NEKTAR THERAPEUTICS
DFNDShares1.28M
TypeSH
Market value$72.64M
2.94%
Sole
0.00
Shared
1.28M
None
0.00
ZYMEWORKS INC
DFNDShares3.94M
TypeSH
Market value$67.27M
2.73%
Sole
0.00
Shared
3.94M
None
0.00
AXSOME THERAPEUTICS INC
DFNDShares486.76K
TypeSH
Market value$59.12M
2.40%
Sole
0.00
Shared
486.76K
None
0.00
AC IMMUNE SA
DFNDShares19.82M
TypeSH
Market value$57.29M
2.32%
Sole
0.00
Shared
19.82M
None
0.00
IMMUNOCORE HLDGS PLC
DFNDShares1.57M
TypeSH
Market value$57.19M
2.32%
Sole
0.00
Shared
1.57M
None
0.00
OLEMA PHARMACEUTICALS INC
DFNDShares5.30M
TypeSH
Market value$51.85M
2.10%
Sole
0.00
Shared
5.30M
None
0.00
TYRA BIOSCIENCES INC
DFNDShares3.65M
TypeSH
Market value$51.06M
2.07%
Sole
0.00
Shared
3.65M
None
0.00
ABIVAX SA
DFNDShares558.03K
TypeSH
Market value$47.38M
1.92%
Sole
0.00
Shared
558.03K
None
0.00
MONTE ROSA THERAPEUTICS INC
DFNDShares5.66M
TypeSH
Market value$41.94M
1.70%
Sole
0.00
Shared
5.66M
None
0.00
4D MOLECULAR THERAPEUTICS IN
DFNDShares4.63M
TypeSH
Market value$40.23M
1.63%
Sole
0.00
Shared
4.63M
None
0.00
STOKE THERAPEUTICS INC
DFNDShares1.66M
TypeSH
Market value$38.94M
1.58%
Sole
0.00
Shared
1.66M
None
0.00
CULLINAN THERAPEUTICS INC
DFNDShares5.75M
TypeSH
Market value$34.10M
1.38%
Sole
0.00
Shared
5.75M
None
0.00
CELCUITY INC
DFNDShares658.42K
TypeSH
Market value$32.53M
1.32%
Sole
0.00
Shared
658.42K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KYMERA THERAPEUTICS INCDFND | COM | 5.50M | SH | $311.45M 12.63% | 0.00 | 5.50M | 0.00 |
REVOLUTION MEDICINES INCDFND | COM | 3.97M | SH | $185.63M 7.52% | 0.00 | 3.97M | 0.00 |
PROTAGONIST THERAPEUTICS INCDFND | COM | 2.56M | SH | $170.12M 6.90% | 0.00 | 2.56M | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 19.75M | SH | $141.62M 5.74% | 0.00 | 19.75M | 0.00 |
CIDARA THERAPEUTICS INCDFND | COM NEW | 1.41M | SH | $135.42M 5.49% | 0.00 | 1.41M | 0.00 |
GH RESEARCH PLCDFND | ORDINARY SHARES | 8.83M | SH | $126.24M 5.12% | 0.00 | 8.83M | 0.00 |
MIRUM PHARMACEUTICALS INCDFND | COM | 1.50M | SH | $109.62M 4.44% | 0.00 | 1.50M | 0.00 |
XOMA ROYALTY CORPORATIONDFND | COM NEW | 2.59M | SH | $99.83M 4.05% | 0.00 | 2.59M | 0.00 |
STRUCTURE THERAPEUTICS INCDFND | SPONSORED ADS | 3.20M | SH | $89.71M 3.64% | 0.00 | 3.20M | 0.00 |
KURA ONCOLOGY INCDFND | COM | 8.62M | SH | $76.26M 3.09% | 0.00 | 8.62M | 0.00 |
SEPTERNA INCDFND | COM | 4.02M | SH | $75.54M 3.06% | 0.00 | 4.02M | 0.00 |
PALVELLA THERAPEUTICS INC NEDFND | COM | 1.16M | SH | $72.80M 2.95% | 0.00 | 1.16M | 0.00 |
NEKTAR THERAPEUTICSDFND | COM NEW | 1.28M | SH | $72.64M 2.94% | 0.00 | 1.28M | 0.00 |
ZYMEWORKS INCDFND | COM | 3.94M | SH | $67.27M 2.73% | 0.00 | 3.94M | 0.00 |
AXSOME THERAPEUTICS INCDFND | COM | 486.76K | SH | $59.12M 2.40% | 0.00 | 486.76K | 0.00 |
AC IMMUNE SADFND | SHS | 19.82M | SH | $57.29M 2.32% | 0.00 | 19.82M | 0.00 |
IMMUNOCORE HLDGS PLCDFND | ADS | 1.57M | SH | $57.19M 2.32% | 0.00 | 1.57M | 0.00 |
OLEMA PHARMACEUTICALS INCDFND | COM | 5.30M | SH | $51.85M 2.10% | 0.00 | 5.30M | 0.00 |
TYRA BIOSCIENCES INCDFND | COM | 3.65M | SH | $51.06M 2.07% | 0.00 | 3.65M | 0.00 |
ABIVAX SADFND | SPONSORED ADS | 558.03K | SH | $47.38M 1.92% | 0.00 | 558.03K | 0.00 |
MONTE ROSA THERAPEUTICS INCDFND | COM | 5.66M | SH | $41.94M 1.70% | 0.00 | 5.66M | 0.00 |
4D MOLECULAR THERAPEUTICS INDFND | COM | 4.63M | SH | $40.23M 1.63% | 0.00 | 4.63M | 0.00 |
STOKE THERAPEUTICS INCDFND | COM | 1.66M | SH | $38.94M 1.58% | 0.00 | 1.66M | 0.00 |
CULLINAN THERAPEUTICS INCDFND | COM | 5.75M | SH | $34.10M 1.38% | 0.00 | 5.75M | 0.00 |
CELCUITY INCDFND | COM | 658.42K | SH | $32.53M 1.32% | 0.00 | 658.42K | 0.00 |
Page 1 of 2